The iPSC-derived neurons obtained with reprogrammed AD patient fibroblasts can mimic the pathological phenomena of AD, like Aβ deposition and tau protein phosphorylation, thus giving a platform to probe the disease mechanism and screen drugs (Sharma et al., 2020). Here, MAPT is linked to Alzheimer disease.